Price
No data yet.
Social Signal Score
70
5d
71
1 mentions
—
30d
70
1 mentions
—
60d
70
1 mentions
—
90d
70
1 mentions
—
news: 1
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management - Global
- Beta
- 0.60
- Country
- US
Quote
Day Range
$83.40 – $85.14
52-Week Range
$64.30 – $85.46
Volume
$168.5K
Market Cap
$3.46B
50-Day Avg
$78.54
200-Day Avg
$74.28
Prev Close
$83.64
Open
$83.61
Valuation & Ratios
P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—
Returns & Efficiency
Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—
Valuation
FHLChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120Aug 23Aug 23
Social Signal Score
70
5d
71
1 mentions
—
30d
70
1 mentions
—
60d
70
1 mentions
—
90d
70
1 mentions
—
news: 1
Mentions (1)
- Newsfool.com·15h ago·Positive
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? Fidelity MSCI Health Care Index ETF (FHLC) offers a significantly lower expense ratio and a higher dividend yield than the Invesco Pharmaceuticals ETF (PJP). PJP provides a concentrated portfolio of just over 30 pharmaceutical stocks, while FHLC diversifies across more than 300 holdings.
View source ↗